Systematic Review and Indirect Treatment Comparison of Dabrafenib and Trametinib versus Other Treatments Used in Previously Untreated Metastatic Melanoma Patients

Kunal Srivastava¹, Mayur M Amonkar^2#, Amit Ahuja^3*, Ceilidh Stapelkamp^4#, Suzanne Swann^5#, Michelle Casey^6# and Cheena Rana⁷

¹BresMed Health Solutions India Pvt. Ltd., Goa, 403601, India

²Novartis Pharmaceuticals Corporation, Wayne, PA, 19087, USA

³HERON: A PAREXEL Company, Chandigarh, 160101, India

⁴Novartis Pharmaceuticals UK Limited, Uxbridge, UB11 1BT, United Kingdom

⁵GlaxoSmithKline, Collegeville, PA, 19426, USA

⁶Pfizer, Collegeville, PA, 19426, USA

⁷Bridge Medical Consultancy Limited, Tonbridge, London, United Kingdom

^#Contributed equally to this work

^*Corresponding Author: Amit Ahuja, HERON: A PAREXEL Company, 3rd Floor, DLF Tower E, Rajiv Gandhi IT Park, Chandigarh - 160101, UT, India, Tel: +91 172 497 1127 Email: